心力衰竭患者中的流感疫苗接种:全国性队列研究
充分校正混杂因素后,接种≥1次疫苗与全因死亡和心血管死亡风险均降低18%相关(HR 0.82)。
要点
- 心衰患者接种流感疫苗与全因和心血管死亡风险降低18%相关(校正后HR 0.82)。
- 未校正分析中接种与死亡风险升高相关,提示需充分校正混杂因素。
核心结论
- 在心衰患者中,经过广泛混杂因素校正后,流感疫苗接种与全因死亡和心血管死亡风险降低相关。
- 频繁接种和年初较早接种与死亡风险降低幅度更大相关,优于间断接种和晚期接种。
研究设计与样本
- 通过全国登记系统链接数据,将随访期间接种状态、次数和频率作为时间变化协变量,采用时间依赖性Cox回归分析。
- 随访率99.8%,中位随访时间3.7年(四分位距1.7–6.8年)。
主要发现
- 研究期间队列疫苗接种覆盖率范围为16%至54%。
- 未校正分析中,随访期间接种≥1次疫苗与死亡风险升高相关。
- 校正纳入日期、合并症、药物、家庭收入和教育水平后,接种≥1次疫苗与全因死亡风险降低18%相关(HR 0.82;95%CI 0.81–0.84;P<0.001)。
- 校正后接种≥1次疫苗与心血管死亡风险降低18%相关(HR 0.82;95%CI 0.81–0.84;P<0.001)。
临床怎么用
- 对于新诊断心衰患者,可考虑建议每年接种流感疫苗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Influenza infection is a serious event for patients with heart failure (HF). Little knowledge exists about the association between influenza vaccination and outcome in patients with HF. This study sought to determine whether influenza vaccination is associated with improved long-term survival in patients with newly diagnosed HF. METHODS: We performed a nationwide cohort study including all patients who were >18 years of age and diagnosed with HF in Denmark in the period of January 1, 2003, to June 1, 2015 (n=134 048). We collected linked data using nationwide registries. Vaccination status, number, and frequency during follow-up were treated as time-varying covariates in time-dependent Cox regression. RESULTS: Follow-up was 99.8% with a median follow-up time of 3.7 years (interquartile range, 1.7-6.8 years). The vaccination coverage of the study cohort ranged from 16% to 54% during the study period. In unadjusted analysis, receiving ≥1 vaccinations during follow-up was associated with a higher risk of death. After adjustment for inclusion date, comorbidities, medications, household income, and education level, receiving ≥1 vaccinations was associated with an 18% reduced risk of death (all-cause: hazard ratio, 0.82; 95% CI, 0.81-0.84; P<0.001; cardiovascular causes: hazard ratio, 0.82; 95% CI, 0.81-0.84; P<0.001). Annual vaccination, vaccination early in the year (September to October), and greater cumulative number of vaccinations were associated with larger reductions in the risk of death compared with intermittent vaccination. CONCLUSIONS: In patients with HF, influenza vaccination was associated with a reduced risk of both all-cause and cardiovascular death after extensive adjustment for confounders. Frequent vaccination and vaccination earlier in the year were associated with larger reductions in the risk of death compared with intermittent and late vaccination.
引用
- Modin D, Jørgensen ME, Gislason G, et al. Influenza Vaccine in Heart Failure. Circulation. 2019. PMID: 30586760. doi:10.1161/CIRCULATIONAHA.118.036788
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。